Sort
130,381 grants matching “hiv”
HIV Monoclonal Antibody Studies
$5,113,889Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
HIV Monoclonal Antibody Studies
$5,109,113Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
The Center for HIV RNA Studies (CRNA)
$5,108,462Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2019 · AI
TRANSITION TO LOCAL OWNERSHIP AND INTEGRATION OF HIV PROGRAMS IN PRIMARY HEALTH C
$5,100,000Namwinga Chintu · Centre For Infectious Disease Research · U2G · FY2011 · GH
University of Washington Center for Aids Research
$5,099,975King Kennard Holmes · University Of Washington · P30 · FY2014 · AI
OCULAR COMPLICATION OF AIDS
$5,096,101Johns Hopkins University · U10 · FY2001 · EY
Molecular Targets Development Program
$5,094,322James McMahon · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP
$5,093,154Fred Hutchinson Cancer Research Center · U01 · FY2002 · AI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$5,092,600Hildegund C. J. Ertl · Wistar Institute · U19 · FY2009 · AI
The Center for HIV RNA Studies (CRNA)
$5,092,588Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2017 · GM
PS04-012, HIV PREVENTION PROJECTS
$5,092,037Marlene McNeese-Ward · Houston Department/Health/Human Srvs · U62 · FY2007 · PS
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis
$5,082,137Jay Evans · Corixa Corporation · N01 · FY2014 · AI
OCULAR COMPLICATION OF AIDS
$5,081,312Johns Hopkins University · U10 · FY2002 · EY
IMPACTA PERU CLINICAL TRIALS UNIT
$5,080,925Javier R Lama · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2019 · AI
Small molecule inhibitors of enveloped virus entry
$5,076,989Sean P. J. Whelan · Harvard Medical School · U19 · FY2017 · AI
B-cell Biology of Mucosal Immune Protection from SIV Challenge
$5,076,283Eric Hunter · Emory University · U19 · FY2013 · AI
PS04-012, HIV PREVENTION PROJECTS
$5,074,744Marlene McNeese-Ward · Houston Department/Health/Human Srvs · U62 · FY2009 · PS
Molecular Targets Development Program
$5,073,784James McMahon · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS
$5,072,696Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI
HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUP
$5,070,741Fred Hutchinson Cancer Research Center · U01 · FY2000 · AI
PS04-012, HIV PREVENTION PROJECTS
$5,069,624M Beth Scalco · Louisiana State Department Of Health · U62 · FY2009 · PS
Development and Production of membrane Proximal External Region (MPER)/ Anti-HIV broadly neutralizing antibodies (bNAbs) for prevention, therapy or cure
$5,069,466Matt Westerman · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA
$5,063,982Grace John-Stewart · University Of Washington · U62 · FY2009 · PS
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY
$5,062,296Thomas N Denny · Duke University · N01 · FY2012 · AI
Terry Beirn CPCRA Clinical Trials Unit
$5,055,518Fred M Gordin · George Washington University · UM1 · FY2016 · AI